Effects of SGLT2i on the Cognitive Function in T2DM Patient (ESCDP)

NCT04304261 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Diabetes Mellitus, Type 2
Cognitive Functions Confusion

Interventions

DRUG: Canagliflozin
DRUG: Sitagliptin

Sponsor

Third Military Medical University